| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Section on Steroid Regulation, Endocrinology and Reproduction Research Branch, NICHD, National Institutes of Health, Bethesda, Maryland 20892-4510
Address all correspondence and requests for reprints to: Dr. Charles A. Strott, Building 49, Room 6A36, National Institutes of Health, Bethesda, Maryland 20892-4510.
In humans, the biotransformation of cholesterol and its hydroxylated metabolites (oxysterols) by sulfonation is a fundamental process of great importance. Nevertheless, the sulfotransferase enzyme(s) that carries out this function has never been clearly identified. Cholesterol is a relatively poor substrate for the previously cloned hydroxysteroid sulfotransferase (HST), i.e. dehydroepiandrosterone (DHEA) sulfotransferase (HST1). Recently, cloning of a single human gene that encodes for two proteins related to HST1 was reported. These newly cloned sulfotransferases (HST2a and HST2b), while exhibiting sequence similarity to other members of the soluble sulfotransferase superfamily, also contain unique structural features. This latter aspect prompted an examination of their substrate specificity for comparison with HST1. Thus, HST1, HST2a, and HST2b were overexpressed as fusion proteins and purified. Furthermore, a novel procedure for the isolation of cholesterol and oxysterol sulfonates was developed that was used in association with HPLC to resolve specific sterol sulfonates. HST1 preferentially sulfonated DHEA and, to a lesser extent, oxysterols; whereas cholesterol was a negligible substrate. The reverse, however, was the case for the HST2 isoforms, particularly HST2b, which preferentially sulfonated cholesterol and oxysterols, in contrast to DHEA, which served as a poor substrate for this enzyme. RT-PCR analysis revealed distinct patterns of HST1, HST2a, and HST2b expression. It was particularly notable that both HST2 isoforms, but not HST1, were expressed in skin, a tissue where cholesterol sulfonation plays an important role in normal development of the skin barrier. In conclusion, substrate specificity and tissue distribution studies strongly suggest that HST2a and HST2b, in contrast to HST1, represent normal human cholesterol and oxysterol sulfotransferases. Furthermore, this study represents the first example of the sulfonation of oxysterols by a specific human HST.
This article has been cited by other articles:
![]() |
X. Li, W. M. Pandak, S. K. Erickson, Y. Ma, L. Yin, P. Hylemon, and S. Ren Biosynthesis of the regulatory oxysterol, 5-cholesten-3{beta},25-diol 3-sulfate, in hepatocytes J. Lipid Res., December 1, 2007; 48(12): 2587 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ji, I. Moon, J. Zlatkovic, O. E. Salavaggione, B. A. Thomae, B. W. Eckloff, E. D. Wieben, D. J. Schaid, and R. M. Weinshilboum Human Hydroxysteroid Sulfotransferase SULT2B1 Pharmacogenomics: Gene Sequence Variation and Functional Genomics J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 529 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fuda, N. B. Javitt, K. Mitamura, S. Ikegawa, and C. A. Strott Oxysterols are substrates for cholesterol sulfotransferase J. Lipid Res., June 1, 2007; 48(6): 1343 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Carroll, G. R. Dubyak, M. M. Sedensky, and P. G. Morgan Sulfated Signal from ASJ Sensory Neurons Modulates Stomatin-dependent Coordination in Caenorhabditis elegans J. Biol. Chem., November 24, 2006; 281(47): 35989 - 35996. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Alnouti and C. D. Klaassen Tissue Distribution and Ontogeny of Sulfotransferase Enzymes in Mice Toxicol. Sci., October 1, 2006; 93(2): 242 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ren, P. Hylemon, Z.-P. Zhang, D. Rodriguez-Agudo, D. Marques, X. Li, H. Zhou, G. Gil, and W. M. Pandak Identification of a novel sulfonated oxysterol, 5-cholesten-3{beta},25-diol 3-sulfonate, in hepatocyte nuclei and mitochondria J. Lipid Res., May 1, 2006; 47(5): 1081 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Kim, J. Shigenaga, A. Moser, C. Grunfeld, and K. R. Feingold Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E731 - E738. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Chang, R. Shi, P. Rehse, and S.-X. Lin Identifying Androsterone (ADT) as a Cognate Substrate for Human Dehydroepiandrosterone Sulfotransferase (DHEA-ST) Important for Steroid Homeostasis: STRUCTURE OF THE ENZYME-ADT COMPLEX J. Biol. Chem., January 23, 2004; 279(4): 2689 - 2696. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott and Y. Higashi Cholesterol sulfate in human physiology: what's it all about? J. Lipid Res., July 1, 2003; 44(7): 1268 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shimizu, H. Fuda, H. Yanai, and C. A. Strott Conservation of the Hydroxysteroid Sulfotransferase SULT2B1 Gene Structure in the Mouse: Pre- and Postnatal Expression, Kinetic Analysis of Isoforms, and Comparison with Prototypical SULT2A1 Endocrinology, April 1, 2003; 144(4): 1186 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Linseisen, G. Wolfram, and A. B. Miller Plasma 7{beta}-Hydroxycholesterol as a Possible Predictor of Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1630 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott Sulfonation and Molecular Action Endocr. Rev., October 1, 2002; 23(5): 703 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fuda, Y. C. Lee, C. Shimizu, N. B. Javitt, and C. A. Strott Mutational Analysis of Human Hydroxysteroid Sulfotransferase SULT2B1 Isoforms Reveals That Exon 1B of the SULT2B1 Gene Produces Cholesterol Sulfotransferase, whereas Exon 1A Yields Pregnenolone Sulfotransferase J. Biol. Chem., September 20, 2002; 277(39): 36161 - 36166. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Stanley, R. Hume, T. J. Visser, and M. W. H. Coughtrie Differential Expression of Sulfotransferase Enzymes Involved in Thyroid Hormone Metabolism during Human Placental Development J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5944 - 5955. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Song, I. Echchgadda, B.-S. Baek, S. C. Ahn, T. Oh, A. K. Roy, and B. Chatterjee Dehydroepiandrosterone Sulfotransferase Gene Induction by Bile Acid Activated Farnesoid X Receptor J. Biol. Chem., November 2, 2001; 276(45): 42549 - 42556. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |